| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/13/2015 | US8933113 Mineralocorticoid receptor antagonists |
| 01/13/2015 | US8933112 Topical liquid to ameliorate pain and promote healing of burn-injured skin |
| 01/13/2015 | US8933111 Crystalline form of (2S,4R)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1H-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester |
| 01/13/2015 | US8933110 Hepatitis C virus inhibitors |
| 01/13/2015 | US8933109 Furo[3, 2-B] pyrrol-3-ones as cathespin S inhibitors |
| 01/13/2015 | US8933108 Benzothiazolone compound |
| 01/13/2015 | US8933106 2-(4-substituted phenylamino) polysubstituted pyridine compounds as inhibitors of non-nucleoside HIV reverse transcriptase, preparation methods and uses thereof |
| 01/13/2015 | US8933105 Pyrrole compounds |
| 01/13/2015 | US8933104 Glucagon receptor modulators |
| 01/13/2015 | US8933103 Pyridone derivatives |
| 01/13/2015 | US8933102 Pyrrolidine derived β3 adrenergic receptor agonists |
| 01/13/2015 | US8933101 Thia(dia)zoles as fast dissociating dopamine 2 receptor antagonists |
| 01/13/2015 | US8933100 Paroxetine derivative |
| 01/13/2015 | US8933099 Monocyclic pyridine derivative |
| 01/13/2015 | US8933098 Dimethyl-benzoic acid compounds |
| 01/13/2015 | US8933097 Fexofenadine suspension formulation |
| 01/13/2015 | US8933096 Antimicrobial agents |
| 01/13/2015 | US8933094 Ethynyl compounds useful for treatment of CNS disorder |
| 01/13/2015 | US8933093 Fluoroergoline analogs |
| 01/13/2015 | US8933092 Methods and compositions comprising sequential administration opioid receptor agonists |
| 01/13/2015 | US8933091 Method of inhibiting C-KIT kinase |
| 01/13/2015 | US8933090 1-aza-bicyclo[3.3.1]nonanes |
| 01/13/2015 | US8933089 HIV inhibiting 5-amido substituted pyrimidines |
| 01/13/2015 | US8933088 Crystalline forms of 3-[5-chloro-4-[(2,4-difluorobenzyl) oxy]-6-oxopyrimidin-1(6H)-yl]-N-(2-hydroxyethyl)-4-methylbenzamide |
| 01/13/2015 | US8933087 Tricyclic proteasome activity enhancing compounds |
| 01/13/2015 | US8933086 Heteroaryl substituted pyrrolo[2,3-B]pyridines and pyrrolo[2,3-B]pyrimidines as Janus kinase inhibitors |
| 01/13/2015 | US8933085 Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as JAK inhibitors |
| 01/13/2015 | US8933084 Macrocyclic compounds as Trk kinase inhibitors |
| 01/13/2015 | US8933083 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/13/2015 | US8933082 Materials and methods for suppressing and/or treating neurofibroma and related tumors |
| 01/13/2015 | US8933081 Melting tablet containing a sildenafil salt |
| 01/13/2015 | US8933080 Bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/13/2015 | US8933079 Pyridone and pyridazinone derivatives as anti-obesity agents |
| 01/13/2015 | US8933078 Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances |
| 01/13/2015 | US8933076 Pyridazine compounds, compositions and methods |
| 01/13/2015 | US8933075 Compounds useful as antiviral agents, compositions, and methods of use |
| 01/13/2015 | US8933074 1,2-disubstituted heterocyclic compounds |
| 01/13/2015 | US8933073 Macrolides and their use |
| 01/13/2015 | US8933072 Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use |
| 01/13/2015 | US8933071 Dimethyl fasudil for inducing polyploidization of megakaryocytes and for treating blood and bone marrow diseases and disorders |
| 01/13/2015 | US8933070 Methods of targeting PTEN mutant diseases and compositions therefor |
| 01/13/2015 | US8933069 Heterocyclic compound |
| 01/13/2015 | US8933068 Composition and methods of treatment of bacterial meningitis |
| 01/13/2015 | US8933067 Pyrido and pyrimidopyrimidine derivatives as anti-profilerative agents |
| 01/13/2015 | US8933066 Compounds for the treatment of hepatitis C |
| 01/13/2015 | US8933065 N-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents |
| 01/13/2015 | US8933063 Preparation of a crystalline antibiotic substance |
| 01/13/2015 | US8933062 Nitric oxide releasing steroids |
| 01/13/2015 | US8933061 Process for the preparation of drospirenone |
| 01/13/2015 | US8933060 Combination of azelastine and ciclesonide for nasal administration |
| 01/13/2015 | US8933059 Natural combination hormone replacement formulations and therapies |
| 01/13/2015 | US8933058 Targetted drug delivery to the bone |
| 01/13/2015 | US8933057 Crystallization method and bioavailability |
| 01/13/2015 | US8933056 Soft protease inhibitors and pro-soft forms thereof |
| 01/13/2015 | US8933054 Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same |
| 01/13/2015 | US8933053 Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in the treatment of cancer |
| 01/13/2015 | US8933052 Uracyl spirooxetane nucleosides |
| 01/13/2015 | US8933050 Methods for the treatment and the diagnosis of cancer |
| 01/13/2015 | US8933049 Repressor on IFN-λ promoter and siRNA against ZEB1 and BLIMP-1 to increase IFN-λ gene activity |
| 01/13/2015 | US8933048 Methods of treating cardiomyopathy |
| 01/13/2015 | US8933046 Influenza targets |
| 01/13/2015 | US8933045 Modulation of human cytomegalovirus replication by micro-RNA 132 (miR132), micro-RNA 145 (mi145) and micro-RNA 212 (miR212) |
| 01/13/2015 | US8933044 RNA interference mediating small RNA molecules |
| 01/13/2015 | US8933040 Selective glycosidase inhibitors and uses thereof |
| 01/13/2015 | US8933037 Methods involving PDGFRBETA inhibitors |
| 01/13/2015 | US8933028 Use of selective estrogen receptor modulator for joint fusion and other repair or healing of connective tissue |
| 01/13/2015 | US8933025 Agent for suppressing postprandial elevation of blood insulin concentration |
| 01/13/2015 | US8933024 Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases |
| 01/13/2015 | US8933022 Methods and compositions for the treatment and prevention Hypoglycemia and related disorders |
| 01/13/2015 | US8933016 Metallodrugs having improved pharmacological properties and methods of manufacture and use thereof |
| 01/13/2015 | US8933013 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory |
| 01/13/2015 | US8933012 Glycopeptide antibiotic derivative |
| 01/13/2015 | US8933011 Treatment of preterm labor with toll-like receptor 9 antagonists |
| 01/13/2015 | US8932867 High purity heparin and production method therefor |
| 01/13/2015 | US8932665 Method for preventing the crystallisation of pharmaceuticals in a polymer film |
| 01/13/2015 | US8932656 Oil blend for skin treatment |
| 01/13/2015 | US8932653 Cleanser compositions and methods for using the same |
| 01/13/2015 | US8932652 Microalgae-derived compositions for improving the health and appearance of skin |
| 01/13/2015 | US8932650 Multifunctional topical formulation for the treatment of acne vulgaris and other skin conditions |
| 01/13/2015 | US8932648 Method of selecting phosphate binder and its uses thereof |
| 01/13/2015 | US8932647 Functional beverage composition |
| 01/13/2015 | US8932645 Composition and methods for relief of chemical sensitivity |
| 01/13/2015 | US8932638 Polyamine derivatives |
| 01/13/2015 | US8932637 Injectable and swellable microspheres for tissue bulking |
| 01/13/2015 | US8932635 Pharmaceutical compositions of hydrophobic surface-modified active substance microparticles for inhalation |
| 01/13/2015 | US8932630 Opioid agonist/antagonist combinations |
| 01/13/2015 | US8932628 Modified release formulations of a bupropion salt |
| 01/13/2015 | US8932627 Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| 01/13/2015 | US8932626 Felbinac-containing transdermally absorbable preparation |
| 01/13/2015 | US8932625 External patch preparation comprising ketoprofen and a specific UV screening agent |
| 01/13/2015 | US8932623 Protective wound dressing device for oral and pharyngeal space |
| 01/13/2015 | US8932622 Tissue coating for preventing undesired tissue-to-tissue adhesions |
| 01/13/2015 | US8932617 Methods for treating or preventing restenosis and other vascular proliferative disorders |
| 01/13/2015 | US8932614 Incorporation of particulate ceragenins in polymers |
| 01/13/2015 | US8932613 Ectoparasite control method |
| 01/13/2015 | US8932610 Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| 01/13/2015 | US8932595 Nicotine immunonanotherapeutics |
| 01/13/2015 | US8932594 Adjuvants and methods of use |
| 01/13/2015 | US8932587 Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase |
| 01/13/2015 | US8932585 Solubilized CoQ-10 |